Want to see IN:SHIVALIK full AI Analyst Report?

Shivalik Rasayan Ltd (SHIVALIK) Price & Analysis

0 Followers

SHIVALIK Stock Chart & Stats

₹358.75

-₹13.65(-1.86%)

At close: Jan 08 4:00 PM EST

₹358.75

-₹13.65(-1.86%)

Day’s Range― - ―

52-Week Range₹206.00 - ₹652.75

Previous CloseN/A

Volume18.40K

Average Volume (3M)1.25K

Market Cap

₹3.61B

Enterprise Value₹4.29B

Total Cash (Recent Filing)₹343.68M

Total Debt (Recent Filing)₹1.14B

Price to Earnings (P/E)29.1

Beta1.03

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.21%

Share Statistics

EPS (TTM)7.55

Shares Outstanding15,750,365

10 Day Avg. Volume987

30 Day Avg. Volume1,247

Financial Highlights & Ratios

PEG Ratio-1.05

Price to Book (P/B)0.58

Price to Sales (P/S)0.94

P/FCF Ratio-5.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative, Low Leverage Balance SheetA conservatively levered balance sheet with debt-to-equity near 0.14–0.22 gives durable financial flexibility. Over the next 2–6 months this supports funding for working capital or capex without aggressive refinancing, strengthens resilience to cyclical demand, and preserves strategic optionality.

Consistent Top-line GrowthSteady annual revenue growth (mid-single to mid-teens) signals resilient end-market demand and successful commercial execution. Sustained top-line expansion provides a foundation for improving operating leverage, supports long-term customer relationships, and underpins future margin recovery if cost control follows.

Diversified Chemical And API Product MixA product mix spanning APIs, intermediates and specialty chemicals exposes the company to multiple structurally steady end-markets (pharma and industrial). This diversification supports recurring revenue, reduces single-market reliance, and bolsters pricing and contract opportunities over time.

Bears Say

Persistent Negative Cash GenerationSustained negative operating and free cash flow since 2023 points to working-capital or cash-conversion stress. Over months this forces reliance on reserves or external financing, constrains reinvestment and dividends, and raises execution risk if cash conversion doesn't improve.

Weakened Profitability And Margin PressureDeclining net income and thinner margins indicate the company is struggling to convert revenue growth into sustainable profits. If margin pressure persists, it will impair cash flow recovery, reduce ability to self-fund growth, and limit long-term returns even with steady revenue trends.

Declining Returns On Equity / Capital EfficiencyROE falling to low single-digits reflects weaker capital efficiency: the company is generating less profit per unit of equity. Persistently low ROE can hinder internal capital accumulation, necessitate external funding for expansion, and compress shareholder value over the medium term.

Shivalik Rasayan Ltd News

Shivalik Rasayan Publishes Audited Results for Quarter and Year Ended March 31, 2026

An announcement from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ) is now available. Shivalik Rasayan Limited announced that its...

2M ago

Shivalik Rasayan Limited Publishes Regulatory Advertisements

The latest update is out from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ). Shivalik Rasayan Limited announced the publication...

10M ago

SHIVALIK FAQ

What was Shivalik Rasayan Ltd’s price range in the past 12 months?

Shivalik Rasayan Ltd lowest stock price was ₹206.00 and its highest was ₹652.75 in the past 12 months.

What is Shivalik Rasayan Ltd’s market cap?

Shivalik Rasayan Ltd’s market cap is ₹3.61B.

When is Shivalik Rasayan Ltd’s upcoming earnings report date?

Shivalik Rasayan Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 15 days.

How were Shivalik Rasayan Ltd’s earnings last quarter?

Shivalik Rasayan Ltd released its earnings results on May 27, 2026. The company reported ₹2.87 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.87.

Is Shivalik Rasayan Ltd overvalued?

According to Wall Street analysts Shivalik Rasayan Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shivalik Rasayan Ltd pay dividends?

Shivalik Rasayan Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.21%. See more information on Shivalik Rasayan Ltd dividends here

What is Shivalik Rasayan Ltd’s EPS estimate?

Shivalik Rasayan Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shivalik Rasayan Ltd have?

Shivalik Rasayan Ltd has 15,750,365 shares outstanding.

What happened to Shivalik Rasayan Ltd’s price movement after its last earnings report?

Shivalik Rasayan Ltd reported an EPS of ₹2.87 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.956%.

Which hedge fund is a major shareholder of Shivalik Rasayan Ltd?

Currently, no hedge funds are holding shares in IN:SHIVALIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Shivalik Rasayan Ltd

Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticides and various other chemicals.